Search for other papers by Yukari Maki in
Google Scholar
PubMed
Search for other papers by Kiyomi Horiuchi in
Google Scholar
PubMed
Search for other papers by Takahiro Okamoto in
Google Scholar
PubMed
treatment, such as quality of life or psychological burden, are essential concerns for cancer survivors ( 6 , 7 ). Besides, labelling people with diagnoses may itself could be harmful to psychological well-being ( 8 , 9 ). Some thoughtful clinicians may
Department of Hematology, University of Groningen, University Medical Center Groningen, The Netherlands
Search for other papers by Hanneke J C M Wouters in
Google Scholar
PubMed
Search for other papers by Bruce H R Wolffenbuttel in
Google Scholar
PubMed
Search for other papers by Anneke C Muller Kobold in
Google Scholar
PubMed
Search for other papers by Thera P Links in
Google Scholar
PubMed
Search for other papers by Gerwin Huls in
Google Scholar
PubMed
Search for other papers by Melanie M van der Klauw in
Google Scholar
PubMed
guidelines. In general, treatment is aimed at abolishing complaints related to hypothyroidism, and normalizing plasma thyroid stimulating hormone (TSH) levels ( 1 ). However, it has been shown that health-related quality of life (HRQoL) improves after 6
Search for other papers by Elizabeth J de Koster in
Google Scholar
PubMed
Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands
Division of Clinical Studies, Institute of Cancer Research, London, UK
Search for other papers by Olga Husson in
Google Scholar
PubMed
Search for other papers by Eveline W C M van Dam in
Google Scholar
PubMed
Search for other papers by G Sophie Mijnhout in
Google Scholar
PubMed
Search for other papers by Romana T Netea-Maier in
Google Scholar
PubMed
Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands
Department of Biomedical Sciences and Humanitas Clinical and Research Centre, Department of Nuclear Medicine, Humanitas University, Milan, Italy
Search for other papers by Wim J G Oyen in
Google Scholar
PubMed
Search for other papers by Marieke Snel in
Google Scholar
PubMed
Department of Radiology, Section of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands
Biomedical Photonic Imaging Group, University of Twente, Enschede, The Netherlands
Search for other papers by Lioe-Fee de Geus-Oei in
Google Scholar
PubMed
Search for other papers by Dennis Vriens in
Google Scholar
PubMed
Search for other papers by for the EfFECTS trial study group in
Google Scholar
PubMed
-effective in a Dutch setting, with lower societal lifelong costs while maintaining the long-term health-related quality of life (HRQoL) in patients undergoing FDG-PET/CT-driven management as compared to routine diagnostic surgery or molecular testing ( 8 , 9
Department of Ultrasound, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
Search for other papers by Yong Yu in
Google Scholar
PubMed
Search for other papers by Lin-Lin Shi in
Google Scholar
PubMed
Search for other papers by Hua-Wei Zhang in
Google Scholar
PubMed
Search for other papers by Qian Wang in
Google Scholar
PubMed
190 44.37 ± 13.88 iU22 Philip SonoVue Retrospective Surgical pathology Wei 2021 China English 48 39.9 ± 10.9 GE LOGIQ E9 Sonazoid Prospective Surgical pathology Quality assessment Two reviewers
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Search for other papers by Heleen I Jansen in
Google Scholar
PubMed
Search for other papers by Marijn M Bult in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Endocrinology and Metabolism, Amsterdam, The Netherlands
Search for other papers by Peter H Bisschop in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Anita Boelen in
Google Scholar
PubMed
Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, The Netherlands
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Amsterdam Reproduction & Development Research Institute, Amsterdam, The Netherlands
Search for other papers by Annemieke C Heijboer in
Google Scholar
PubMed
Amsterdam UMC location University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam, The Netherlands
Search for other papers by Jacquelien J Hillebrand in
Google Scholar
PubMed
the immunometric ECLIA assay (Gen I) on the Cobas e601 platform (Roche, reference interval 0.5–5.0 mU/L). Multilevel internal quality controls (Randox Immuno L1 and L2) were measured daily. The laboratory participated in the Dutch external quality
Search for other papers by Waleed K W Al-Badri in
Google Scholar
PubMed
Search for other papers by Hinke Marijke Jellema in
Google Scholar
PubMed
Search for other papers by Arnaud R G G Potvin in
Google Scholar
PubMed
Search for other papers by Ruth M A van Nispen in
Google Scholar
PubMed
Search for other papers by Peter H Bisschop in
Google Scholar
PubMed
Search for other papers by Peerooz Saeed in
Google Scholar
PubMed
eyelid retraction, diplopia, and even corneal ulceration and optic neuropathy ( 1 ). All these clinical manifestations make GO a vision-threatening and disfiguring illness, heavily affecting the quality of life (QoL) and mental well-being of patients. GO
Search for other papers by Jakub Supronik in
Google Scholar
PubMed
Search for other papers by Małgorzata Szelachowska in
Google Scholar
PubMed
Clinical Research Centre, Medical University of Bialystok, Bialystok, Poland
Search for other papers by Adam Kretowski in
Google Scholar
PubMed
Search for other papers by Katarzyna Siewko in
Google Scholar
PubMed
social life. Even disease classified as mild according to ophthalmic criteria may impair the patient’s quality of life (QoL) drastically. It is recommended to assess the QoL of patients by providing them with a standardized questionnaire, which might help
Search for other papers by Line Tang Møllehave in
Google Scholar
PubMed
Search for other papers by Marie Holm Eliasen in
Google Scholar
PubMed
Search for other papers by Ieva Strēle in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Allan Linneberg in
Google Scholar
PubMed
Université Libre de Bruxelles, Bruxelles, Belgium
Search for other papers by Rodrigo Moreno-Reyes in
Google Scholar
PubMed
Search for other papers by Ludmila B Ivanova in
Google Scholar
PubMed
School of Medicine, Zagreb, Croatia
Search for other papers by Zvonko Kusić in
Google Scholar
PubMed
Search for other papers by Iris Erlund in
Google Scholar
PubMed
Search for other papers by Till Ittermann in
Google Scholar
PubMed
Search for other papers by Endre V Nagy in
Google Scholar
PubMed
Department of Clinical Nutrition, Landspitali-National University Hospital, Reykjavik, Iceland
Search for other papers by Ingibjorg Gunnarsdottir in
Google Scholar
PubMed
Goldman School of Medicine, Ben Gurion University of the Negev, Beer Sheva, Israel
Search for other papers by Jonathan Eli Arbelle in
Google Scholar
PubMed
Search for other papers by Aaron Milton Troen in
Google Scholar
PubMed
Search for other papers by Valdis Pīrāgs in
Google Scholar
PubMed
Search for other papers by Lisbeth Dahl in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Malgorzata Trofimiuk-Müldner in
Google Scholar
PubMed
Search for other papers by João Jacome de Castro in
Google Scholar
PubMed
Search for other papers by Mafalda Marcelino in
Google Scholar
PubMed
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Search for other papers by Simona Gaberšček in
Google Scholar
PubMed
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Search for other papers by Katja Zaltel in
Google Scholar
PubMed
Universitat Autònoma de Barcelona, Barcelona, Spain
Search for other papers by Manuel Puig-Domingo in
Google Scholar
PubMed
Search for other papers by Lluis Vila in
Google Scholar
PubMed
Frölunda Specialist Hospital, Västra Frölunda, Sweden
Search for other papers by Sofia Manousou in
Google Scholar
PubMed
Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Wallenberg Centre of Molecular and Translational Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
Search for other papers by Michael Bruce Zimmermann in
Google Scholar
PubMed
Search for other papers by Karen R Mullan in
Google Scholar
PubMed
Search for other papers by Jayne Valerie Woodside in
Google Scholar
PubMed
Search for other papers by Henry Völzke in
Google Scholar
PubMed
Search for other papers by Betina Heinsbæk Thuesen in
Google Scholar
PubMed
established ( 6 , 7 ). However, the availability and applicability of register data for assessment of thyroid outcomes from the European countries have not yet been examined. After a thorough assessment of the quality and comparability of data across
Medical College, Shantou University, Shantou, China
Search for other papers by Xiaoyi Qi in
Google Scholar
PubMed
Search for other papers by Liangxian Qiu in
Google Scholar
PubMed
Search for other papers by Shijia Wang in
Google Scholar
PubMed
Search for other papers by Xiongbiao Chen in
Google Scholar
PubMed
Search for other papers by Qianwen Huang in
Google Scholar
PubMed
Medical College, Shantou University, Shantou, China
Search for other papers by Yixuan Zhao in
Google Scholar
PubMed
Search for other papers by Kunfu Ouyang in
Google Scholar
PubMed
Search for other papers by Yanjun Chen in
Google Scholar
PubMed
% confidence intervals (95% CIs) and adjusted covariates for multivariable analysis. Quality assessment We used the Newcastle–Ottawa Scale (NOS) to evaluate the quality of the eligible cohort studies ( 9 ). The NOS is a nine-point scale that allocates
Search for other papers by Rasmus Reinke in
Google Scholar
PubMed
Search for other papers by Stefano Christian Londero in
Google Scholar
PubMed
Search for other papers by Martin Almquist in
Google Scholar
PubMed
Search for other papers by Lars Rejnmark in
Google Scholar
PubMed
Search for other papers by Lars Rolighed in
Google Scholar
PubMed
) or their vascular supply ( 3 ). HypoPT may reduce quality of life ( 4 ) and increases both mortality ( 5 ) and morbidity ( 6 ). Morbidity for patients with hypoPT includes an increased risk of developing chronic kidney disease (CKD) and kidney